Navigation Links
Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report
Date:4/23/2008

armaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA immunotherapeutics for cancer, in which the expressed protein is an immune system stimulant; DNA vaccines for infectious diseases, in which the expressed protein is an immunogen; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and serve significant unmet medical needs. Additional information on Vical is available at http://www.vical.com.

This press release contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected, including: whether Vical or others will continue development of Allovectin-7(R); whether Vical will be able to recruit patients into the AIMM trial as planned, if at all; whether the results from the Phase 2 trial or those reflected in the video report are indicative of results in any future testing of Allovectin-7(R); whether Vical will receive all of the clinical trial funding from AnGes under the collaborative agreement, which will depend on continued development of Allovectin-7(R) and certain other conditions, as well as AnGes' compliance with its contractual obligations under the agreement; whether Vical or others will evaluate potential additional applications of the company's technology; whether Allovectin-7(R) or any other product candidates will be shown to be saf
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
2. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
3. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
4. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
5. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
6. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
7. Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant
8. New Study Shows Listeria Vaccine for Cervical Cancer Found Safe
9. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
10. Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
11. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 An analysis ... regarding patients taking Sovaldi® (sofosbuvir), a new and expensive ... shows that over the last several months (May through ... downward trend in Sovaldi utilization. This suggests another surge ... new therapeutic regimens of similar efficacy and shorter duration ...
(Date:9/17/2014)... Sept. 17, 2014  Aratana Therapeutics, Inc. (NASDAQ: ... on licensing, developing and commercializing innovative biopharmaceutical products ... its public offering of 4,500,000 shares of its common stock ... per share. Aratana has granted the underwriters a ... 675,000 shares of its common stock. ...
(Date:9/17/2014)... , Sept. 17, 2014 Sutro Biopharma, a ... and the biopharmaceutical division of Merck KGaA, Darmstadt, ... in the United States and ... and license agreement to develop antibody drug conjugates (ADCs). ... cytotoxic drug. The antibody is thought to specifically target ...
Breaking Medicine Technology:CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 2CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 3CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies 4Aratana Therapeutics, Inc. Announces Pricing of Public Offering 2Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 2Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 3Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 4
... Dehaier Medical Systems Ltd. (NASDAQ: ... in the development, assembly, marketing and sale of medical ... Company,s growing business earned a BBB+ Credit Rating from the ... and was approved as a member of the association. ...
... /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP ) ("ShangPharma" ... research and development outsourcing company, today announced that it ... quarter and full year ended December 31, 2011 on ... to discuss the results at 08:00AM New York Time ...
Cached Medicine Technology:Dehaier Medical Awarded Strong Credit Rating From Beijing Zhongguancun Enterprises Credit Promotion Association 2Dehaier Medical Awarded Strong Credit Rating From Beijing Zhongguancun Enterprises Credit Promotion Association 3ShangPharma to Report Fourth Quarter and Full Year 2011 Financial Results on March 13, 2012 2
(Date:9/17/2014)... September 17, 2014 Representatives with Capitol ... sponsor of Thursday’s Anti-Defamation League Event at the Four Seasons ... we consider it an honor to be a sponsor for ... Pain Institute. , Schocket went on to explain that the ... 600 community leaders and members at the Four Seasons to ...
(Date:9/17/2014)... Texas (PRWEB) September 17, 2014 ... provides key market data on the North America ... millions of US dollars, volume (in units) and ... –, Female Sterilization Devices ... (Tubal Clips and Rings)) , Endometrial ...
(Date:9/17/2014)... Kamut International is pleased to announce that ... Michael Angelo’s new “Made With Organic” ready-made, frozen meals ... ready made, frozen meal. Michael Angelo’s products feature KAMUT® ... products align well with Kamut International’s mission to support ... must be grown certified organic. , The new “Made ...
(Date:9/17/2014)... 17, 2014 Promising new research published ... more light on the potential ability of ketones to ... dementia. The study shows that brain ... caused by impaired glucose uptake and/or utilization, and results ... function. , The study, by the Research Center on ...
(Date:9/17/2014)... Right now no one can say whether yoga provides ... a new article in the Journal of Psychiatric ... scores of people with the condition who practice yoga. ... be a substantial help, but it sometimes carries risks, ... yoga for bipolar disorder," said lead author Lisa Uebelacker, ...
Breaking Medicine News(10 mins):Health News:Capitol Pain Institute Sponsoring an Anti-Defamation League Event & Awards Dinner 2Health News:Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org 2Health News:Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org 3Health News:Gynecological Devices Market in North America (US, Canada & Mexico) to 2020 New Report Available at MarketOptimizer.org 4Health News:KAMUT® Brand Wheat Delivers a High Quality Ingredient and Authentic Italian Taste for Michael Angelo’s New Ready-Made Meals featuring Organic Ingredients 2Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 2Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 3Health News:Survey finds benefits, risks of yoga for bipolar disorder 2Health News:Survey finds benefits, risks of yoga for bipolar disorder 3
... Point Action Plan on infectious waste control during a ... Monday,s Washington Times (link below), Emergency Preparedness ... issues, such as SARS, have highlighted the vulnerability our ... the area of operational sustainability in a crisis. ...
... visits to doctors and hospitals by people with the disease ... are still reporting new cases of infection with the H1N1 ... in visits to doctors and hospitals by people with the ... health official said Thursday. , "At the national level, ...
... Congress Urged to Support Bill for Bone Health Promotion ... (NOF) in conjunction with the National Coalition for Osteoporosis ... Hill today to engage Congress in an action plan ... lawmakers to sign on to the "Bone Health Promotion ...
... early were more likely to have been victims , , ... when they started menstruating, the more likely black women ... report. , The finding suggests childhood sexual abuse may ... at more than 35,000 women, aged 21 to 69, ...
... Link Services, CaseworkersPHILADELPHIA, May 21 The Field ... the University of Pennsylvania has announced ... Change, Microsoft Corp. and Motorola to pilot the ... private entities, this groundbreaking interoperable, real-time technology system ...
... 2009 Issue Examines Experiences of Denton ... Center DALLAS, May 21 T-System, Inc., the ... departments and urgent care centers, today announced that its Emergency ... in a column entitled "ED Information Systems: A Guideline For ...
Cached Medicine News:Health News:Coalition Calls on Secretary of Health to Make Hospital Emergency Preparedness a Priority 2Health News:Swine Flu Outbreak May Be Subsiding, CDC Says 2Health News:Swine Flu Outbreak May Be Subsiding, CDC Says 3Health News:Swine Flu Outbreak May Be Subsiding, CDC Says 4Health News:Swine Flu Outbreak May Be Subsiding, CDC Says 5Health News:Swine Flu Outbreak May Be Subsiding, CDC Says 6Health News:Swine Flu Outbreak May Be Subsiding, CDC Says 7Health News:Swine Flu Outbreak May Be Subsiding, CDC Says 8Health News:Swine Flu Outbreak May Be Subsiding, CDC Says 9Health News:Swine Flu Outbreak May Be Subsiding, CDC Says 10Health News:Swine Flu Outbreak May Be Subsiding, CDC Says 11Health News:Swine Flu Outbreak May Be Subsiding, CDC Says 12Health News:Swine Flu Outbreak May Be Subsiding, CDC Says 13Health News:The National Coalition for Osteoporosis and Related Bone Diseases Briefed Congress on Action Plan for a National Vision for Bone Health 2Health News:The National Coalition for Osteoporosis and Related Bone Diseases Briefed Congress on Action Plan for a National Vision for Bone Health 3Health News:The National Coalition for Osteoporosis and Related Bone Diseases Briefed Congress on Action Plan for a National Vision for Bone Health 4Health News:The National Coalition for Osteoporosis and Related Bone Diseases Briefed Congress on Action Plan for a National Vision for Bone Health 5Health News:Childhood Sexual Abuse Might Spur Early Periods 2Health News:University of Pennsylvania, Montgomery County Partner on Integrated, Interoperable System Design for Child Welfare 2Health News:The T SystemEV(R) Featured in Journal of Emergency Nursing Paper on Successful EDIS Implementation 2Health News:The T SystemEV(R) Featured in Journal of Emergency Nursing Paper on Successful EDIS Implementation 3
Prostate biopsy transducer....
Multi-frequency, HST, linear transducer with a longer (60mm) footprint. Available with puncture adapter and water path. This transducer incorporates ALOKAs exclusive Hemispheric Sound Technology and ...
... high frequency (13Mhz) ... and superficial imaging. ... Hemispheric Sound Technology ... This multi-frequency transducer ...
... an excellent choice for a ... wide scan angle. With muliple ... designed for a wide view ... versatility of this transducer provides ...
Medicine Products: